News

Immunizations Should Precede Rituximab


 

The only significant predictor of vaccine response was IgG2 level at the time of immunization for tetanus, PPV23, and KLH vaccines, he said, noting that “age, methotrexate dose, concomitant corticosteroid use, diagnosis of diabetes mellitus, skin test anergy [less than 5-mm induration], IgM, IgA, total IgG, and IgG1, IgG3, and IgG4 subsets were not predictors of immunization response, nor did rituximab affect total IgG or IgG2 levels.”

Dr. Bingham has served as a consultant to Genentech Inc. and to Roche.

Pages

Recommended Reading

Statins May Benefit Arthritis Patients With High CRP
MDedge Rheumatology
Vaccinations Are Key to Infection Control in TNF Blockers
MDedge Rheumatology
MRI Improved Care of Some Knee Pain Patients
MDedge Rheumatology
Switching Anti-TNF Agents Is Common, but Unstudied
MDedge Rheumatology
JIA Flare Triggers Macrophage Activation
MDedge Rheumatology
New Pain Guidelines Take Aim at NSAIDs
MDedge Rheumatology
Etanercept Significantly Helped Heel Enthesitis
MDedge Rheumatology
Methotrexate/Tocilizumab Combo Offers New Option for RA
MDedge Rheumatology
Retreatment With Rituximab Promoted Clinical Response
MDedge Rheumatology
Joint Decisions
MDedge Rheumatology